Orexo seeks approval of nasal high-dose opioid rescue medicine
Fast-dissolving opioid dependence tablet wins EU recommendation - Drug Delivery Business
Orexo sues Actavis and Teva over narcotic dependency treatment
Full Year Report incl. Q4 2017
Opioid Use Disorder Market Analysis to 2027 - Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros
Teva Can Challenge Validity of Orexo Patent (Corrected)
Suboxone sales down as opioid addiction drug market intensifies
Orexo removes overhang on shares with key court win | Evaluate
Orexo partners with Gaia on digital opioid abuse therapeutic | Pharmaphorum
Orexo
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Orexo misses out on millions after losing patent infringement suit against Actavis
Teva, denying 'any liability,' set aside $646M for opioid settlements. Here's why | Fierce Pharma
Orexo Acquires Exclusive US Rights to Commercialize deprexis - IndiaMedToday
Orexo enters patent infringement litigation against Actavis
Patent Litigation Updates: CRISPR, Acorda's Ampyra, and Orexo Versus Teva | BioSpace
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE OREXO AB and OREXO US, INC., Plaintiffs, ACTA VIS ELIZABETH LLC
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
In opioid case, NY wants to probe Teva's control of Teva USA
Annual Report
Teva extends global rebrand with tailored marketing messages for caregivers | Fierce Pharma
Opioid Use Disorder Market Growth to register a CAGR of 8.7% to reach USD US$ 4,911.8 Million by 2028 | Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, | Medgadget
Orexo AB - Org Chart, Teams, Culture & Jobs | The Org
Orexo Ruling Hugely Significant | Potter Clarkson
Teva Seeks to Consolidate Price-Fixing, Opioid Lawsuits
Domstol afviser omhøring af patentsag mellem Teva og Novo-firmaet Orexo — MedWatch
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE OREXO AB and OREXO US, INC., Plaintiffs, ACTAVIS ELIZABETH LLC,
